Subscribe

Remedent, Inc. (REMI)

USD0.00 +0.00 (+0.00%)
BE OTC Healthcare Medical - Instruments & Supplies
Address Zuiderlaan 1-3 9000
Gent, BE
CEO Guy De Vreese
IPO 2006-03-01
CIK 1078037 ISIN US75954T1043

Explore sections of this company profile

Description

Remedent, Inc., operating through its various subsidiaries, specializes in the research, development, manufacturing, and distribution of products for both oral hygiene and aesthetic dentistry. The company's core offerings include professional-grade dental veneers and teeth whitening systems, designed for use by dental practitioners as well as for over-the-counter purchase by consumers. Its innovative product portfolio features River8, a pre-fabricated veneer solution that assists dentists in achieving optimal tooth alignment with minimal patient tooth reshaping. Additionally, Remedent supplies GlamSmile veneers, which are exceptionally thin shells bonded to the front surfaces of a patient's teeth. Beyond physical products, the company offers a suite of digital tools and services aimed at enhancing dental practice operations. These include the SmileMe Mirror, an integrated marketing concept that enables quick smile consultations in about ten minutes; SmileSketch, simulation software capable of creating visual previews of potential aesthetic results; and various "Treatment Pages" designed to explain the advantages of specific dental procedures. Furthermore, Remedent provides the Condor, an advanced intra-oral 3D scanning device. The company's expertise also extends to dental implant technologies and related treatment methodologies. Remedent distributes its products to dental professionals in nearly 30 countries, spanning regions such as Asia, Europe, the Middle East, Canada, and the United States, utilizing both its internal sales team and third-party distributors. Founded in 1986, the company's corporate headquarters are located in Ghent, Belgium.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.00 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
17.5K
Beta
-0.43
Float Shares
12.73M
Free Float %
63.7%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +0.00% +0.00% +0.00% +133.33% +16.67% -96.26% -99.59% -99.59% -99.56% -99.97%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.00
Ratings Trend (MoM)
Rating 2024-11 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-5.70
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
3 / 10
No MOAT
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Instruments & Supplies: +7.9%
    +14.2% Q1'24: +22.0% (vs Q1'23)
  • EPS growth Medical - Instruments & Supplies: +16.3%
    +81.7% Q1'24: +55.8% (vs Q1'23)
  • FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%
    -19.6% Q1'24: -36.4% (vs Q1'23)
  • EBIT margin Medical - Instruments & Supplies: +13.5%
    -23.8% Q1'24: -82.1% (vs Q1'23)
  • ROIC Medical - Instruments & Supplies: +6.0%
    -9.7% Q1'24: -34.4% (vs Q1'23)
  • Share dilution Medical - Instruments & Supplies: +0.1%
    +0.0% Q1'24: +0.0% (vs Q1'23)
  • Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×
    -0.07× Q1'24: -0.02× (vs Q1'23)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (-0.44) × ERP
WACC = 47% × Ke + 53% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 0.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-123.7K
OE per share TTM
-0.01
Owner's Yield
-884.00%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
5.5%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
4
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Austin W. Marxe and David M. Greenhouse 3.95M 19.80% 2.00 3.95M IA, IN 00 2013-01-10
2 Stuart Sternberg 3.01M 15.10% 3.01M 3.01M IN United States 2015-12-02
3 Jon D. Gruber 1.96M 9.40% 1.70M 1.70M IN California 2010-02-02
4 Gruber and McBaine Capital Management, LLC. 175.8K 0.90% 175.8K 175.8K IA, OO California 2013-02-13

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
2
Sells
0
Shares acquired
799.6K
Shares disposed
Cash buys
2.00
Cash sales
Net activity
+799,638
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2015-12-02 Sternberg Stuart 10% Owner P-Purchase A Common Stock, no par value 399,819 0.15 60.0K 3,011,534
2013-07-24 Sternberg Stuart 10% Owner D Common Stock, no par value 0 0.00 2,533,793
2013-07-24 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner S-Sale D Common Stock 2,848,408 0.09 242.4K 0
2013-07-19 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner S-Sale D Common Stock 165,000 0.10 16.5K 2,848,908
2013-07-18 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner S-Sale D Common Stock 225,000 0.10 22.6K 3,013,908
2013-07-16 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner S-Sale D Common Stock 713,025 0.09 67.5K 3,238,908
2012-12-03 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner S-Sale D Common Stock 200,000 0.12 24.0K 3,951,933
2012-11-30 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner S-Sale D Common Stock 45,000 0.12 5.4K 4,151,933
2012-11-29 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner S-Sale D Common Stock 84,000 0.12 10.3K 4,196,933
2012-11-28 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner S-Sale D Common Stock 5,000 0.15 750.00 4,280,933
2012-07-18 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner S-Sale D Common Stock 175,000 0.25 43.8K 4,345,933
2012-06-25 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner J-Other D Warrants 1,500,000 1.55 2.33M 0
2012-02-28 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner S-Sale D Common Stock 11,000 0.40 4.4K 4,520,933
2012-02-27 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner S-Sale D Common Stock 10,000 0.40 4.0K 4,531,933
2012-02-16 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner S-Sale D Common Stock 4,000 0.37 1.5K 4,541,933
2012-02-15 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner S-Sale D Common Stock 5,000 0.33 1.7K 4,545,933
2012-02-13 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner S-Sale D Common Stock 30,000 0.28 8.4K 4,550,933
2011-08-25 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner S-Sale D Common Stock 400 0.25 100.00 4,580,933
2011-01-31 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 500 0.65 325.00 4,581,333
2011-01-27 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 25,000 0.75 18.7K 4,580,833
2011-01-24 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 1,899 0.65 1.2K 4,555,833
2011-01-21 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 7,500 0.65 4.9K 4,553,934
2011-01-20 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 15,000 0.65 9.8K 4,546,434
2011-01-19 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 29,000 0.52 15.2K 4,509,434
2009-10-27 GRUBER & MCBAINE CAPITAL MANAGEMENT LLC 10% Owner S-Sale D Common Stock 7,200 0.38 2.7K 1,695,200
2009-07-31 Ross Stephen Farley Director / Officer P-Purchase A Common Stock 100 0.52 52.00 463,827
2009-07-16 Ross Stephen Farley Director / Officer P-Purchase A Common Stock 100 0.65 65.00 463,727
2009-05-28 Ross Stephen Farley Director / Officer P-Purchase A Common Stock 200 0.75 150.00 463,627
2009-05-12 Ross Stephen Farley Director / Officer P-Purchase A Common Stock 150 0.90 135.00 463,427
2009-03-19 Van Acker Philippe Director A-Award A Option 100,000 0.50 50.0K 100,000
2009-03-19 Ross Stephen Farley Director / Officer A-Award A Option 100,000 0.50 50.0K 100,000
2009-03-19 Kolsteeg Fred Director A-Award A Option 200,000 0.50 100.0K 200,000
2008-12-23 Ross Stephen Farley Director / Officer P-Purchase A Common Stock 2,000 0.40 800.00 463,277
2008-12-17 Ross Stephen Farley Director / Officer P-Purchase A Common Stock 5,000 0.45 2.3K 461,277
2008-12-10 List Robin D-Return D Common Stock 723,000 0.00 9,827
2008-02-27 Leddington Roger Officer P-Purchase A Common Stock 2,000 1.14 2.3K 3,000
2007-12-18 DeVreese Guy Director / Officer G-Gift D Common Stock 600,000 0.00 1,400,000
2007-08-17 Leddington Roger Officer A-Award A Option 100,000 1.50 150.0K 100,000
2007-08-10 DeVreese Guy Director / Officer G-Gift A Common Stock 3,151,426 0.00 3,154,426
2007-08-08 Leddington Roger Officer D Common Stock 0 0.00 1,000
2007-06-26 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 2,000,000 1.25 2.50M 7,647,101
2007-06-22 GRUBER & MCBAINE CAPITAL MANAGEMENT LLC 10% Owner P-Purchase A Warrants 0 1.55 729,600
2007-03-30 Kolsteeg Fred Director P-Purchase A Common Stock 50,000 1.45 72.5K 95,000
2006-12-29 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 19,000 1.50 28.5K 4,147,101
2006-12-28 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 33,000 1.50 49.5K 4,128,101
2006-12-27 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 10,000 1.40 14.0K 4,095,101
2006-12-26 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 20,000 1.45 29.0K 4,085,101
2006-07-17 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 15,000 1.80 27.0K 4,065,101
2006-07-10 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 100,000 1.80 180.0K 4,050,101
2006-07-07 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 100,000 1.90 190.0K 3,950,101
2006-06-26 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 7,000 2.10 14.7K 3,850,101
2006-06-21 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 2,500 2.10 5.3K 3,843,101
2006-06-20 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 4,000 2.10 8.4K 3,840,601
2006-06-08 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 4,000 2.10 8.4K 3,836,601
2006-06-05 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 9,900 2.06 20.4K 3,832,601
2006-05-25 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 6,000 2.00 12.0K 3,822,701
2006-05-19 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 5,000 2.00 10.0K 3,816,701
2006-05-18 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 1,000 2.00 2.0K 3,811,701
2006-05-15 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 4,000 1.98 7.9K 3,810,701
2006-05-02 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 1,000 2.25 2.3K 3,806,701
2006-05-02 DeVreese Guy Director / Officer / 10% Owner S-Sale D Common Stock 127,641 2.25 287.2K 3,224,213
2006-04-18 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 10,500 2.10 22.1K 3,805,701
2006-04-17 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 23,000 2.20 50.6K 3,795,201
2006-04-10 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 10,000 2.20 22.0K 3,772,201
2006-04-07 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 45,000 2.35 105.8K 3,762,201
2006-04-06 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 4,500 2.30 10.4K 3,717,201
2006-04-05 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 50,167 2.41 120.9K 3,712,701
2006-04-04 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 106,700 2.50 266.8K 3,662,534
2006-04-03 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 178,500 2.25 401.6K 3,555,834
2006-03-31 Ross Stephen Farley Director / Officer 0 0.00 0
2006-03-30 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner P-Purchase A Common Stock 42,000 2.58 108.4K 3,375,334
2006-01-19 DeVreese Guy Director / Officer G-Gift D Common Stock 3,942,075 0.00 3,351,854
2006-01-18 DeVreese Guy Director / Officer G-Gift A Common Stock 137,928 0.00 7,293,929
2006-01-05 DeVreese Guy Director / Officer J-Other D Common Stock 93,533 1.50 140.3K 6,467
2005-10-17 Hoffman Judd Darrin Officer D Option 400,000 4.00 1.60M 0
2005-07-08 MARXE AUSTIN W & GREENHOUSE DAVID M 10% Owner I Warrants 1,666,667 1.75 2.92M 0
2005-06-03 List Robin Officer J-Other A Common Stock 622,202 0.00 732,827
2005-06-03 Lausha NV 10% Owner D Common Stock 0 0.00 0
2005-06-03 DeVreese Guy Director / Officer J-Other A Common Stock 7,093,501 1.00 7.09M 7,156,001
2003-03-31 Ross Stephen Farley Director / Officer P-Purchase A Stock Options 250,000 0.01 2.5K 250,000
2002-08-21 Lausha NV 10% Owner D Warrants to Purchase Common Stock 8,680 1.00 8.7K 0
2002-03-29 Van Acker Philippe Officer D Options to Purchase Common Stock 10,000 1.00 10.0K 0
2002-03-29 Ross Stephen Farley Director / Officer P-Purchase A Stock Opotions 1,000,000 0.05 50.0K 1,000,000
2002-03-29 List Robin Director / Officer P-Purchase A Stock Options 1,000,000 0.05 50.0K 1,000,000
2002-03-29 Kolsteeg Fred Director P-Purchase A Stock Options 100,000 0.05 5.0K 100,000
2002-03-29 DeVreese Guy Director / 10% Owner P-Purchase A Stock Options 1,000,000 0.05 50.0K 1,000,000
2002-01-11 Kolsteeg Fred Director P-Purchase A Warrants 200,000 0.50 100.0K 200,000
2002-01-11 DeVreese Guy Director / 10% Owner P-Purchase A Warrants 173,400 0.50 86.7K 173,400

Executive team

Top executives
EBIT / Employee
-78.3K
Shares Outstanding
20.00M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2007 Guy De Vreese, Chairman, CEO of Remedent 294.4K 294.4K 0.00%
2 2007 Robin List, CEO 239.0K 239.0K 0.00%
3 2007 Philippe Van Acker, CFO 138.6K 138.6K 0.00%
4 2006 Philippe Van Acker, CFO 122.0K 180.0K 302.0K 59.60%
5 2006 Guy De Vreese, Chairman, CEO of Remedent 222.0K 222.0K 0.00%
6 2006 Robin List, CEO 213.0K 213.0K 0.00%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2021-06-30 8-K
2021-06-29 15-12G
2021-02-16 10-Q
2020-11-16 10-Q
2020-08-14 10-Q
2020-06-29 10-K
2020-02-14 10-Q
2019-11-14 10-Q
2019-08-14 10-Q
2019-06-28 10-K

Executive team

NameTitleCompensationGender
Philippe Van Acker Chief Financial Officer, Chief Accounting Officer & Director 188.0K male
Guy De Vreese Chairman & Chief Executive Officer male
ESG Rating
B
MEDICAL - INSTRUMENTS & SUPPLIES
2020
E (Environmental)
64.6 / 64.7
Company / Sector avg.
S (Social)
68.1 / 70.0
Company / Sector avg.
G (Governance)
62.7 / 67.5
Company / Sector avg.
ESG Total
65.1 / 67.4
Company / Sector avg.
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits